ENDOMETRIN Drug Patent Profile
✉ Email this page to a colleague
When do Endometrin patents expire, and what generic alternatives are available?
Endometrin is a drug marketed by Ferring and is included in one NDA.
The generic ingredient in ENDOMETRIN is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the progesterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Endometrin
A generic version of ENDOMETRIN was approved as progesterone by FRESENIUS KABI USA on April 25th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ENDOMETRIN?
- What are the global sales for ENDOMETRIN?
- What is Average Wholesale Price for ENDOMETRIN?
Summary for ENDOMETRIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 116 |
Clinical Trials: | 18 |
Patent Applications: | 4,321 |
Drug Prices: | Drug price information for ENDOMETRIN |
What excipients (inactive ingredients) are in ENDOMETRIN? | ENDOMETRIN excipients list |
DailyMed Link: | ENDOMETRIN at DailyMed |


See drug prices for ENDOMETRIN

Recent Clinical Trials for ENDOMETRIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Clinique Ovo | Phase 2 |
The University of Hong Kong | Phase 3 |
Meir Medical Center | N/A |
Pharmacology for ENDOMETRIN
Drug Class | Progesterone |
US Patents and Regulatory Information for ENDOMETRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferring | ENDOMETRIN | progesterone | INSERT;VAGINAL | 022057-001 | Jun 21, 2007 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ENDOMETRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ferring | ENDOMETRIN | progesterone | INSERT;VAGINAL | 022057-001 | Jun 21, 2007 | ⤷ Try for Free | ⤷ Try for Free |
Ferring | ENDOMETRIN | progesterone | INSERT;VAGINAL | 022057-001 | Jun 21, 2007 | ⤷ Try for Free | ⤷ Try for Free |
Ferring | ENDOMETRIN | progesterone | INSERT;VAGINAL | 022057-001 | Jun 21, 2007 | ⤷ Try for Free | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ENDOMETRIN
See the table below for patents covering ENDOMETRIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 1176200 | ⤷ Try for Free | |
European Patent Office | 2386291 | ⤷ Try for Free | |
Israel | 127129 | METHOD FOR PREPARATION OF PROGESTERONE TABLETS FOR VAGINAL DELIVERY AND TABLETS SO PREPARED | ⤷ Try for Free |
Japan | 2002529494 | ⤷ Try for Free | |
Japan | 4667601 | ⤷ Try for Free | |
Spain | 2390959 | ⤷ Try for Free | |
World Intellectual Property Organization (WIPO) | 0028970 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ENDOMETRIN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2782584 | 132021000000197 | Italy | ⤷ Try for Free | PRODUCT NAME: ESTRADIOLO (17SS-ESTRADIOLO) IN PARTICOLARE NELLA FORMA EMIIDRATA, E PROGESTERONE COMPRENDENTI LE VARIE FORME DI ESTRADIOLO (17SS-ESTRADIOLO), QUALI LE FORME IDRATE E SOLVATATE, INCLUDENDO LA FORMA EMIIDRATA, ED I SUOI SALI.(BIJUVA); AUTHORISATION NUMBER(S) AND DATE(S): BE582231, 20210406;048335018 -048335020, 20210517 |
2782584 | 2021C/558 | Belgium | ⤷ Try for Free | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17--ESTRADIOL), EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (Y COMPRIS SOUS FORME HEMIHYDRATEE), ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210406 |
2861072 | 2024C/512 | Belgium | ⤷ Try for Free | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL, EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE (Y COMPRIS SOUS FORME HEMIHYDRATEE) ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210406 |
2782584 | 21C1058 | France | ⤷ Try for Free | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17SS-ESTRADIOL), Y COMPRIS SOUS FORME HEMIHYDRATEE, ET DE LA PROGESTERONE; NAT. REGISTRATION NO/DATE: NL51886 20210421; FIRST REGISTRATION: BE - BE582231 20210406 |
2782584 | 301153 | Netherlands | ⤷ Try for Free | PRODUCT NAME: COMPOSITION CONTAINING BOTH ESTRADIOL (17SS-ESTRADIOL), OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE THEREOF (INCLUDING IN HEMIHYDRATE FORM), AND PROGESTERONE; NATIONAL REGISTRATION NO/DATE: RVG 125821 20210611; FIRST REGISTRATION: BE BE582231 20210406 |
0113964 | 97C0037 | Belgium | ⤷ Try for Free | PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826 |
2782584 | LUC00245 | Luxembourg | ⤷ Try for Free | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17SS-ESTRADIOL), EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (Y COMPRIS SOUS FORME HEMIHYDRATEE), ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210701 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for Endometriosis Treatments: A Focus on Emerging Therapies
More… ↓